-
New monoclonal antibodies designed to stop Epstein Barr virus from attaching to and entering human immune cells
Medical Mythbusting Commentary for April 16, 2026 Source:95% of people carry this virus and scientists may have just found how to stop it Reference:Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.